You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Viagenex Max

Showing 1 - 25 of 368
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Erectile Dysfunction Trial in Atlanta (VIAGENEX Max, Hibiclens wash)

Recruiting
  • Erectile Dysfunction
  • VIAGENEX Max
  • Hibiclens wash
  • Atlanta, Georgia
    Atlanta Cosmetic Urology
Jan 4, 2022

Orthosis to Improve Trunk Control in Infants Age 6-18 Months

Not yet recruiting
  • Cerebral Palsy
  • SPIO® Core-MAX® Expedition thoracolumbosacral orthosis
  • (no location specified)
Sep 6, 2023

Central Venous Catheter Trial in Überlingen, Leipzig (Central Venous Access)

Not yet recruiting
  • Central Venous Catheter
  • Central Venous Access
  • Überlingen, Baden Württemberg, Germany
  • +1 more
Feb 20, 2023

Deglutition Trial in Toulouse (Remote follow-up)

Not yet recruiting
  • Deglutition
  • Remote follow-up
  • Toulouse, France
    CHU Toulouse
Jan 6, 2023

Cervical Pain Trial in Islamabad (Cervical spine manipulation, traction)

Completed
  • Cervical Pain
  • Cervical spine manipulation
  • traction
  • Islamabad, Pakistan
    Dr. Abdul Gaffoor
Oct 12, 2022

Lung Metastases, Colorectal Cancer Metastatic Trial in Amsterdam (Minimally invasive pulmonary metastasectomy, Stereotactic

Not yet recruiting
  • Lung Metastases
  • Colorectal Cancer Metastatic
  • Minimally invasive pulmonary metastasectomy
  • Stereotactic ablative radiotherapy
  • Amsterdam, Netherlands
    Amsterdam University Medical Center (AUMC)
Apr 10, 2023

Idiopathic Intracranial Hypertension, Intracranial Pressure, Obesity Trial in Glostrup, Odense (drug, dietary supplement,

Recruiting
  • Idiopathic Intracranial Hypertension
  • +5 more
  • Glostrup, Denmark
  • +1 more
Sep 7, 2023

Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli

Recruiting
  • Treatment Compliance
  • to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
  • Karachi, Sindg, Pakistan
  • +1 more
Oct 6, 2022

Nova Max Creatinine and eGFR Meter System

Recruiting
  • Chronic Kidney Diseases
  • Acute Kidney Injury
  • Creatinine, eGFR
  • Medley, Florida
  • +2 more
Sep 27, 2022

Lactating Mothers and Their Newborns to Unravel Complexity of

Not yet recruiting
  • Breast Feeding
  • Milk, Human
    • Utrecht, Netherlands
      Danone Nutricia Research
    Jul 31, 2023

    Cognitive Change Trial in Canfield (Placebo, AmaTea Guayusa Extract, Lion's Mane)

    Completed
    • Cognitive Change
    • Placebo
    • +2 more
    • Canfield, Ohio
      The Center for Applied Health Sciences
    Sep 29, 2023

    Knee Osteoarthritis Trial (ACP Max™, Depo-Medrol®)

    Not yet recruiting
    • Knee Osteoarthritis
    • ACP Max™
    • Depo-Medrol®
    • (no location specified)
    Mar 1, 2023

    Respiratory Disease Trial in Basingstoke (Maximal 6-minute Walk Test (Max_6MWT), Normal speed 6-minute Walk Test (Nor_6MWT))

    Recruiting
    • Respiratory Disease
    • Maximal 6-minute Walk Test (Max_6MWT)
    • Normal speed 6-minute Walk Test (Nor_6MWT)
    • Basingstoke, United Kingdom
      Hampshire Hospitals NHS Foundation Trust
    Jan 30, 2023

    Manufacture of Clinical T-cell Products for Future Treatment

    Completed
    • Virus-specific T Cells
    • Leukapheresis
    • Basel, Switzerland
      University Hospital Basel, Departement Infektiologie & Spitalhyg
    Feb 3, 2023

    Hernia, Inguinal, Hernia, Direct Inguinal Trial in Gdansk (Non-fixation of the mesh, Fixation of the mesh)

    Recruiting
    • Hernia, Inguinal
    • Hernia, Direct Inguinal
    • Non-fixation of the mesh
    • Fixation of the mesh
    • Gdańsk, Poland
      Swissmed Hospital
    Feb 1, 2023

    Anxiety, Surgery Trial (Virtual Parental Presence on Induction of Anesthesia, Midazolam)

    Not yet recruiting
    • Anxiety
    • Surgery
    • Virtual Parental Presence on Induction of Anesthesia
    • Midazolam
    • (no location specified)
    Apr 27, 2023

    Kesimpta® Treatment Effects in Relapsing Multiple Sclerosis

    Recruiting
    • Multiple Sclerosis
    • Ofatumumab
    • Bamberg, Bavaria, Germany
    • +21 more
    Jan 25, 2023

    Chronic Coronary Syndrome Trial (telemonitoring, control follow-up)

    Not yet recruiting
    • Chronic Coronary Syndrome
    • telemonitoring
    • control follow-up
    • (no location specified)
    May 23, 2023

    Pyridoxine Dependant Epilepsy Trial in Nijmegen, London (PDE MAX)

    Recruiting
    • Pyridoxine Dependant Epilepsy
    • PDE MAX
    • Nijmegen, Netherlands
    • +1 more
    Dec 7, 2021

    Metachromatic Leukodystrophy Trial in Durham (Enriched Hematopoetic Stem Cell Infusion)

    No longer available
    • Metachromatic Leukodystrophy
    • Enriched Hematopoetic Stem Cell Infusion
    • Durham, North Carolina
      Duke University
    Jul 15, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in Nanjing (MAX-40279)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Nanjing, Jingsu, China
      Nanjing Drum Tower Hospital of Nanjing University Medical School
    May 29, 2022

    Dietary Impact on Continuous Glucose Monitoring

    Not yet recruiting
    • Glucose Metabolism Disorders
    • +3 more
      • (no location specified)
      Apr 25, 2023

      Pi Max and Diaphragm Maximum Inspiratory Excursion Detected With

      Recruiting
      • Weaning
      • +2 more
      • diaphragm ultrasound
      • Sabadell, Barcelona, Spain
        Candelaria De Haro
      Apr 26, 2022

      Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

      Completed
      Has Results
      • Pancreatic Adenocarcinoma
      • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
      • +3 more
      • Dallas, Texas
        UT Southwestern Medical Center
      Oct 10, 2022

      Alzheimer's Disease Trial (CS6253 Solution for Injection, Placebo)

      Not yet recruiting
      • Alzheimer's Disease
      • CS6253 Solution for Injection
      • Placebo
      • (no location specified)
      Jul 20, 2023